Hepatitis C

Bristol-Myers buying heart drug maker Cardioxyl for $2.1B

Bristol-Myers Squibb Company is acquiring a private biotech company developing a medicine for one of the most common cause of hospitalizations in senior citizens, in a deal that could be worth up to USD 2.1 billion.

Nov 03, 2015, 22:48 PM IST

Drug from banana substance may help fight AIDS

A substance originally found in bananas and carefully edited by scientists could lead to drugs that fight off a wide range of viruses, including those that cause AIDS, Hepatitis C and influenza, new research suggests.

Oct 23, 2015, 12:47 PM IST

22 infected with Hepatitis C virus in Singapore

Of the 22 infected, the youngest is 24 years old, and the remaining are between 50 and 60 years old.

Oct 06, 2015, 23:53 PM IST

Dr Reddy's shares up on Hepatitis C drug launch plan

Shares of Dr Reddy's Laboratories on Tuesday settled with gains of nearly 2 percent after the firm said it is planning to launch Hepatitis C drug in the country, following which its market capitalisation rose Rs 1,000 crore.

Mar 24, 2015, 19:08 PM IST

Dr Reddy's to launch Hepatitis C drug in India

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Mar 23, 2015, 17:50 PM IST